EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSBMUG00000016382
Gene Symbol: HDAC11
3 Cross references
198 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSBMUG00000005689
Gene Symbol: HDAC2
3 Cross references
201 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSBMUG00000022826
Gene Symbol: HDAC3
3 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSBMUG00000023531
Gene Symbol: HDAC4
3 Cross references
263 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSBMUG00000019271
Gene Symbol: HDAC5
3 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSBMUG00000005294
Gene Symbol: HDAC6
3 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSBMUG00000001600
Gene Symbol: HDAC7
3 Cross references
263 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSBMUG00000007782
Gene Symbol: HDAC8
1 Cross references
204 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSBMUG00000026402
Gene Symbol: HDAC9
3 Cross references
233 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 2

Ensembl ID : ENSBMUG00000017162
Gene Symbol: LOC102278645
2 Cross references
164 Possible Orthologues:

Hydroxysteroid 11-Beta Dehydrogenase 1

Ensembl ID : ENSBMUG00000006788
Gene Symbol: HSD11B1
3 Cross references
267 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSBMUG00000012306
Gene Symbol: HCN4
1 Cross references
288 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).